Replies to post #98411 on Biotech Values

[mcbio]

Re: IDX-320 Phase 1b results

...and the reporting of data from the phase-1b IDX320 study will not be especially consequential in its own right.

It will presumably be useful to see the results to compare potency to the more advanced HCV PIs like Telaprevir and the 2nd gen PIs like ACH-1625.